Abstract
Although cisplatin is indispensable for the chemotherapy treatment of many malignancies, cisplatin-associated thrombosis is attracting increasing attention. However, experience of primary percutaneous coronary intervention (PCI) and intravascular ultrasound imaging (IVUS) for coronary thrombosis, possibly due to cisplatin-based chemotherapy, has been limited. Case 1 with postoperative gastric cancer developed acute myocardial infarction (AMI) on the sixth day of the second chemotherapy course with conventional doses of cisplatin and tegafur gimeracil oteracil potassium. Emergency coronary angiography (CAG) showed a filling defect in the proximal left anterior descending coronary artery (LAD) concomitant with no reflow in the distal LAD. Case 2 with advanced lung cancer and brain metastasis suffered AMI on the fifth day of the first chemotherapy course with conventional doses of cisplatin and gemcitabine. Emergency CAG delineated a total occlusion in the proximal right coronary artery. In both cases, thrombectomy using aspiration catheter alone obtained optimal angiographic results and subsequent IVUS revealed no definite atherosclerotic plaque, while slow flow still remained even after selective intra-coronary infusion of vasodilator in the case 1. These cases suggest that primary PCI using thrombus-aspiration catheter might be safe and effective for coronary thrombosis due to cisplatin-based chemotherapy.
Similar content being viewed by others
References
Jafri M, Protheroe A (2008) Cisplatin-associated thrombosis. Anticancer Drugs 19:927–929
Starling N, Rao S, Cunningham D, Iveson T, Nicolson M, Coxon F, Middleton G, Daniel F, Oates J, Norman AR (2009) Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group. J Clin Oncol 27:3786–3793
Dieckmann KP, Gerl A, Witt J, Hartmann JT, German Testicular Cancer Study Group (2010) Myocardial infarction and other major vascular events during chemotherapy for testicular cancer. Ann Oncol 21:1607–1611
Fukunaga T, Soejima H, Sugamura K, Kojima S, Sugiyama S, Sakamoto T, Yoshimura M, Tanoue T, Kageshita T, Ono T, Ogawa H (2006) Acute myocardial infarction induced by cisplatin-based combination chemotherapy for malignant melanoma: a case report. J Cardiol 47:191–195
Grzybczak R, Undas A, Rostoff P, Gackowski A, Czubek U, Stopyra K, Piwowarska W (2010) Life-threatening cardiac manifestations of primary antiphospholipid syndrome. Heart Vessels 25:267–269
Ariyoshi M, Shiraishi J, Kimura M, Matsui A, Takeda M, Arihara M, Hyogo M, Shima T, Okada T, Kohno Y, Sawada T, Matsubara H (2011) Primary percutaneous coronary intervention for acute myocardial infarction due to possible sequelae of Kawasaki disease in young adults: a case series. Heart Vessels 26:117–124
Silverstein RL, Nachman RL (1992) Cancer and clotting—Trousseau’s warning. N Engl J Med 327:1163–1164
Prandoni P, Falanga A, Piccioli A (2005) Cancer and venous thromboembolism. Lancet Oncol 6:401–410
Sallah S, Wan JY, Nguyen NP (2002) Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thromb Haemost 87:575–579
Wahrenbrock M, Borsig L, Le D, Varki N, Varki A (2003) Selectin–mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest 112:853–862
Kardasz I, De Caterina R (2007) Myocardial infarction with normal coronary arteries: a conundrum with multiple aetiologies and variable prognosis: an update. J Intern Med 261:330–348
Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ 3rd (2000) Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 160:809–815
Mafrici A, Alberti A, Corrada E, Ferrari S, Marenna B (2003) Management of patients with persistent chest pain and ST-segment elevation during 5-fluorouracil treatment: report about two cases. Ital Heart J 4:895–899
Mermershtain W, Dudnik J, Gusakova I, Ariad S (2001) Acute myocardial infarction in a young man receiving chemotherapy for testicular cancer: case report. J Chemother 13:658–660
Nuver J, Smit AJ, van der Meer J, van den Berg MP, van der Graaf WT, Meinardi MT, Sleijfer DT, Hoekstra HJ, van Gessel AI, van Roon AM, Gietema JA (2005) Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer. J Clin Oncol 23:9130–9137
Lü CF, Yu HJ, Hou JX, Zhou J (2008) Increased procoagulant activity of red blood cells in the presence of cisplatin. Chin Med J 121:1775–1780
Hansen SW, Olsen N, Rossing N, Rørth M (1990) Vascular toxicity and the mechanism underlying Raynaud’s phenomenon in patients treated with cisplatin, vinblastine and bleomycin. Ann Oncol 1:289–292
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ito, D., Shiraishi, J., Nakamura, T. et al. Primary percutaneous coronary intervention and intravascular ultrasound imaging for coronary thrombosis after cisplatin-based chemotherapy. Heart Vessels 27, 634–638 (2012). https://doi.org/10.1007/s00380-011-0222-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-011-0222-5